Pulse wave velocity as a marker of cardiovascular disease

​Description of research

  • Pulse wave velocity as a marker of cardiovascular disease
    The clarify the explanatory factors of pulse wave velocity (arterial stiffness) in cross-sectional analysis and in patients studied 10 years ago.

  • Measurement of hypertension
    Status of home blood pressure measurement in estimation of high blood poressure

  • Fabry disease
    The effect of enzyme replacement therapy in Fabry diseasePulse wave velocity as a marker of cardiovascular disease

Members of the research group

Teemu Niiranen MD, PhD
Ville Langen MD
Annika Lindroos, MD
Sam Siven, MD
Eeva Juhanoja, MD
Jouni Johansson, MD,PhD
Arttu Lehtonen, MD
Essi Roine, study nurse
Jenni Raali, study nurse

Selected publications 

Korhonen PE, Kivelä SL, Aarnio PT, Kautiainen H, Järvenpää S, Kantola IM. Estimating glomerular filtration rate in hypertensive subjects: Comparison of the Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) and Modification of Diet in Renal Disease (MDRD) Study equations. Ann Med 2012; 44: 487-93. (CI 3,763)
Niiranen TJ, Leino K, Puukka P, Kantola I, Karanko H, Jula AM. Lack of impact of a comprehensive intervention on hypertension in the primary care setting. Am J Hypertens. 2014;27:489-96. (CI 3,182)
Korhonen PE, Ettala O, Kautiainen H, Kantola I. Factors modifying the effect of blood pressure on erectile function. J Hypertens 2015; 33: 975-80. (CI 5,062)
Lindroos AS, Johansson JK, Puukka PJ, Kantola I, Salomaa V, Juhanoja EP, Sivén SS, Jousilahti P, Jula AM, Niiranen TJ. The association between home vs. ambulatory night-time blood pressure and end-organ damage in the general population. J Hypertens. 2016;34:1730-7. (CI 5,062)
Sivén SS, Niiranen TJ, Kantola IM, Jula AM. White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Fin-Home study. J Hypertens. 2016;34:54-60. (CI 5,062)